<div id="readability-page-1"><div><p>(MT Newswires) -- Eyebright Medical Technology (Beijing) (SHA:688050) obtained market registration approval from China's medical products administrator for its extended depth of focus intraocular lens.</p><p> The product is intended for vision correction after adult cataract surgery, according to a filing with the Shanghai bourse.</p><p>Shares of the medical device manufacturer closed 2% higher Monday.</p></div></div>

爱博医疗

<p>（MT Newswires）-- 爱博医疗科技（北京）（SHA:688050）获得中国医疗产品管理局对其延伸焦深人工晶体的市场注册批准。根据上海证券交易所的文件，该产品旨在用于成人白内障手术后的视力矫正。该医疗器械制造商的股票周一收盘上涨 2%</p>

爱博医疗科技获得了人工晶状体的市场准入许可